therapy
-
AstraZeneca breast cancer drug camizestrant fails pivotal SERENA-4 trial as first-line therapy
AstraZeneca announced on Friday that its investigational breast cancer treatment, camizestrant, failed to meet its primary endpoint in the pivotal…
-
The Duchenne muscular dystrophy gene therapy Elevidys has become a lightning rod.
Roche announced on Thursday its intention to conduct an additional clinical trial for Elevidys, a gene therapy targeting Duchenne muscular…
Featured
Latest
Lucas Brey
I’m Lucas Brey, a travel blogger sharing practical guides, hidden gems, and honest tips from the road. Follow along for smart itineraries, great food finds, and stories worth bookmarking.
